{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cucurbitacins", "Inhibitors", "Kinase", "Pruritus", "TrkA"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31694615", "DateCompleted": {"Year": "2020", "Month": "01", "Day": "01"}, "DateRevised": {"Year": "2020", "Month": "01", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "11", "Day": "06"}], "Language": ["eng"], "ELocationID": ["295", "10.1186/s12906-019-2709-z"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "19", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Nov", "Day": "06"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Identification and characterization of the Cucurbitacins, a novel class of small-molecule inhibitors of Tropomyosin receptor kinase a.", "Pagination": {"StartPage": "295", "MedlinePgn": "295"}, "Abstract": {"AbstractText": ["NGF-TrkA is well known to play a key role in propagating and sustaining pruritogenic signals, which form the pathology of chronic pruritus. Inhibition of NGF-TrkA is a known strategy for the treatment of pruritus. In the present paper, we describe the identification, in vitro characterization, structure-activity analysis, and inhibitory evaluation of a novel TrkA inhibitory scaffold exemplified by Cucurbitacins (Cus).", "Cus were identified as TrkA inhibitors in a large-scale kinase library screen. To obtain structural models of Cus as TrkA inhibitors, AutoDock was used to explore their binding to TrkA. Furthermore, PC12 cell culture systems have been used to study the effects of Cus and traditional Chinese medicinal plants (Tian Gua Di and bitter gourd leaf) extracts on the kinase activity of TrkA.", "Cus block the phosphorylation of TrkA on several tyrosine sites, including Tyr490, Tyr674/675, and Tyr785, and inhibit downstream Akt and MAPK phosphorylation in response to NGF in PC12 cell model systems. Furthermore, traditional Chinese medicinal plants (Tian Gua Di and bitter gourd leaf) containing Cu extracts were shown to inhibit the phosphorylation of TrkA and Akt. These data reveal mechanisms, at least partly, of the anti-pruritus bioactivity of Cus.", "Taken together, with the recent discovery of the important role of TrkA as a therapeutic target, Cus could be the basis for the design of improved TrkA kinase inhibitors, which could someday help treat pruritus."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China."}], "LastName": "Zhong", "ForeName": "Yueling", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Laboratory Medicine, Chengdu Medical College, Chengdu, China."}], "LastName": "Xu", "ForeName": "Hong", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China."}], "LastName": "Zhong", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Laboratory Medicine, Chengdu Medical College, Chengdu, China."}], "LastName": "Zhang", "ForeName": "Xuemiao", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Scientific Research, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Sichuan Province, China."}], "LastName": "Zeng", "ForeName": "Ting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China."}], "LastName": "Li", "ForeName": "Limei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China."}], "LastName": "Xu", "ForeName": "Gaojie", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Scientific Research, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Sichuan Province, China."}], "LastName": "Li", "ForeName": "Minhui", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China. jinliu@cmc.edu.cn."}, {"Identifier": [], "Affiliation": "Center for Scientific Research, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Sichuan Province, China. jinliu@cmc.edu.cn."}], "LastName": "Liu", "ForeName": "Jin", "Initials": "J"}, {"Identifier": ["0000-0002-5606-325X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Chengdu Sichuan Province, China. taiyang@cmc.edu.cn."}, {"Identifier": [], "Affiliation": "Center for Scientific Research, Chengdu Medical College, No.783, Xindu Avenue, Xindu District, Chengdu, 610500, Sichuan Province, China. taiyang@cmc.edu.cn."}], "LastName": "Yang", "ForeName": "Tai", "Initials": "T"}], "GrantList": [{"GrantID": "NO. 81201668", "Agency": "Scientific Research Fund of the National Natural Science Foundation of China", "Country": ""}, {"GrantID": "2015-HM01-00506-SF", "Agency": "Chengdu Science and Technology Bureau", "Country": ""}, {"GrantID": "NO. 17CZ0011, 17ZA0109", "Agency": "Scientific Research Fund of the Sichuan Provincial Education Department", "Country": ""}, {"GrantID": "NO. CYCG15-01", "Agency": "Scientific Research Fund of Chengdu Medical College", "Country": ""}, {"GrantID": "S2016-25", "Agency": "Scientific Research Fund of CMA - L'OREAL China Skin/Hair", "Country": ""}, {"GrantID": "201613705009, 201613705070, 201613705092", "Agency": "National Undergraduates Innovating Experimentation Project", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "60137-06-6", "NameOfSubstance": "Cucurbitacins"}, {"RegistryNumber": "9061-61-4", "NameOfSubstance": "Nerve Growth Factor"}, {"RegistryNumber": "EC 2.7.10.1", "NameOfSubstance": "Receptor, trkA"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Amino Acid Motifs"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cucumis melo"}, {"QualifierName": ["chemistry"], "DescriptorName": "Cucurbitacins"}, {"QualifierName": ["chemistry"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["chemistry"], "DescriptorName": "Fruit"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": ["chemistry"], "DescriptorName": "Momordica charantia"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nerve Growth Factor"}, {"QualifierName": [], "DescriptorName": "PC12 Cells"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["antagonists & inhibitors", "chemistry"], "DescriptorName": "Receptor, trkA"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kaushik U, Aeri V, Mir SR. Cucurbitacins - an insight into medicinal leads from nature. Pharmacogn Rev. 2015;9(17):12\u201318. doi: 10.4103/0973-7847.156314.", "ArticleIdList": ["10.4103/0973-7847.156314", "PMC4441156", "26009687"]}, {"Citation": "Sikander M, Hafeez BB, Malik S, Alsayari A, Halaweish FT, Yallapu MM, Chauhan SC, Jaggi M. Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer. Sci Rep. 2016;6:36594. doi: 10.1038/srep36594.", "ArticleIdList": ["10.1038/srep36594", "PMC5100479", "27824155"]}, {"Citation": "Hung CM, Chang CC, Lin CW, Chen CC, Hsu YC. GADD45gamma induces G2/M arrest in human pharynx and nasopharyngeal carcinoma cells by cucurbitacin E. Sci Rep. 2014;4:6454. doi: 10.1038/srep06454.", "ArticleIdList": ["10.1038/srep06454", "PMC4171705", "25245461"]}, {"Citation": "Rios JL, Andujar I, Escandell JM, Giner RM, Recio MC. Cucurbitacins as inducers of cell death and a rich source of potential anticancer compounds. Curr Pharm Des. 2012;18(12):1663\u20131676. doi: 10.2174/138161212799958549.", "ArticleIdList": ["10.2174/138161212799958549", "22443631"]}, {"Citation": "Dong Y, Lu B, Zhang X, Zhang J, Lai L, Li D, Wu Y, Song Y, Luo J, Pang X, et al. Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway. Carcinogenesis. 2010;31(12):2097\u20132104. doi: 10.1093/carcin/bgq167.", "ArticleIdList": ["10.1093/carcin/bgq167", "20732905"]}, {"Citation": "Zheng Q, Liu Y, Liu W, Ma F, Zhou Y, Chen M, Chang J, Wang Y, Yang G, He G. Cucurbitacin B inhibits growth and induces apoptosis through the JAK2/STAT3 and MAPK pathways in SHSY5Y human neuroblastoma cells. Mol Med Rep. 2014;10(1):89\u201394. doi: 10.3892/mmr.2014.2175.", "ArticleIdList": ["10.3892/mmr.2014.2175", "24789581"]}, {"Citation": "Nakashima S, Matsuda H, Kurume A, Oda Y, Nakamura S, Yamashita M, Yoshikawa M. Cucurbitacin E as a new inhibitor of cofilin phosphorylation in human leukemia U937 cells. Bioorg Med Chem Lett. 2010;20(9):2994\u20132997. doi: 10.1016/j.bmcl.2010.02.062.", "ArticleIdList": ["10.1016/j.bmcl.2010.02.062", "20347305"]}, {"Citation": "Zhang Y, Ouyang D, Xu L, Ji Y, Zha Q, Cai J, He X. Cucurbitacin B induces rapid depletion of the G-actin pool through reactive oxygen species-dependent actin aggregation in melanoma cells. Acta Biochim Biophys Sin Shanghai. 2011;43(7):556\u2013567. doi: 10.1093/abbs/gmr042.", "ArticleIdList": ["10.1093/abbs/gmr042", "21642275"]}, {"Citation": "Zhu JS, Ouyang DY, Shi ZJ, Xu LH, Zhang YT, He XH. Cucurbitacin B induces cell cycle arrest, apoptosis and autophagy associated with G actin reduction and persistent activation of cofilin in Jurkat cells. Pharmacology. 2012;89(5\u20136):348\u2013346. doi: 10.1159/000338757.", "ArticleIdList": ["10.1159/000338757", "22699368"]}, {"Citation": "Yang T, Liu J, Yang M, Huang N, Zhong Y, Zeng T, Wei R, Wu Z, Xiao C, Cao X, et al. Cucurbitacin B exerts anti-cancer activities in human multiple myeloma cells in vitro and in vivo by modulating multiple cellular pathways. Oncotarget. 2017;8(4):5800\u20135813.", "ArticleIdList": ["PMC5351590", "27418139"]}, {"Citation": "Goldstein DM, Gray NS, Zarrinkar PP. High-throughput kinase profiling as a platform for drug discovery. Nat Rev Drug Discov. 2008;7(5):391\u2013397. doi: 10.1038/nrd2541.", "ArticleIdList": ["10.1038/nrd2541", "18404149"]}, {"Citation": "Munoz L. Non-kinase targets of protein kinase inhibitors. Nat Rev Drug Discov. 2017.", "ArticleIdList": ["28280261"]}, {"Citation": "Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682\u2013690. doi: 10.1038/nchembio.118.", "ArticleIdList": ["10.1038/nchembio.118", "18936753"]}, {"Citation": "Pearce LR, Alton GR, Richter DT, Kath JC, Lingardo L, Chapman J, Hwang C, Alessi DR. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1) Biochem J. 2010;431(2):245\u2013255. doi: 10.1042/BJ20101024.", "ArticleIdList": ["10.1042/BJ20101024", "20704563"]}, {"Citation": "Tyler RK, Shpiro N, Marquez R, Eyers PA. VX-680 inhibits Aurora a and Aurora B kinase activity in human cells. Cell Cycle. 2007;6(22):2846\u20132854. doi: 10.4161/cc.6.22.4940.", "ArticleIdList": ["10.4161/cc.6.22.4940", "18032922"]}, {"Citation": "Vogt J, Traynor R, Sapkota GP. The specificities of small molecule inhibitors of the TGFss and BMP pathways. Cell Signal. 2011;23(11):1831\u20131842. doi: 10.1016/j.cellsig.2011.06.019.", "ArticleIdList": ["10.1016/j.cellsig.2011.06.019", "21740966"]}, {"Citation": "Shimoke K, Sasaya H, Ikeuchi T. Analysis of the role of nerve growth factor in promoting cell survival during endoplasmic reticulum stress in PC12 cells. Methods Enzymol. 2011;490:53\u201370. doi: 10.1016/B978-0-12-385114-7.00003-9.", "ArticleIdList": ["10.1016/B978-0-12-385114-7.00003-9", "21266243"]}, {"Citation": "Chen X, Bao J, Guo J, Ding Q, Lu J, Huang M, Wang Y. Biological activities and potential molecular targets of cucurbitacins: a focus on cancer. Anti-Cancer Drugs. 2012;23(8):777\u2013787. doi: 10.1097/CAD.0b013e3283541384.", "ArticleIdList": ["10.1097/CAD.0b013e3283541384", "22561419"]}, {"Citation": "Roblin D, Yosipovitch G, Boyce B, Robinson J, Sandy J, Mainero V, Wickramasinghe R, Anand U, Anand P: Topical TrkA kinase inhibitor CT327 is an effective, novel therapy for the treatment of pruritus due to psoriasis: results from in vitro and tissue experimental studies, and efficacy and safety of CT327 in a phase 2b, Randomised, Double-blind, Vehicle-controlled Clinical Trial in Patients with Psoriasis. Acta dermato-venereologica 2015.", "ArticleIdList": ["25594427"]}, {"Citation": "Liu M, Zhao G, Cao S, Zhang Y, Li X, Lin X. Development of certain protein kinase inhibitors with the components from traditional Chinese medicine. Front Pharmacol. 2016;7:523.", "ArticleIdList": ["PMC5220067", "28119606"]}, {"Citation": "Duong-Ly KC, Peterson JR. A high-throughput radiometric kinase assay. Methods Mol Biol. 2016;1360:87\u201395. doi: 10.1007/978-1-4939-3073-9_7.", "ArticleIdList": ["10.1007/978-1-4939-3073-9_7", "PMC5131709", "26501904"]}, {"Citation": "Ma H, Horiuchi KY. Chemical microarray: a new tool for drug screening and discovery. Drug Discov Today. 2006;11(13\u201314):661\u2013668. doi: 10.1016/j.drudis.2006.05.002.", "ArticleIdList": ["10.1016/j.drudis.2006.05.002", "PMC2577215", "16793536"]}, {"Citation": "Schulte-Herbruggen O, Folster-Holst R, von Elstermann M, Augustin M, Hellweg R. Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis. Int Arch Allergy Immunol. 2007;144(3):211\u2013216. doi: 10.1159/000103994.", "ArticleIdList": ["10.1159/000103994", "17579279"]}, {"Citation": "Yamaguchi J, Aihara M, Kobayashi Y, Kambara T, Ikezawa Z. Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis. J Dermatol Sci. 2009;53(1):48\u201354. doi: 10.1016/j.jdermsci.2008.08.011.", "ArticleIdList": ["10.1016/j.jdermsci.2008.08.011", "18922683"]}, {"Citation": "Jeong Y, Lim SM, Hong S. Discovery of wrightiadione as a novel template for the TrkA kinase inhibitors. Bioorg Med Chem Lett. 2015;25(22):5186\u20135189. doi: 10.1016/j.bmcl.2015.09.070.", "ArticleIdList": ["10.1016/j.bmcl.2015.09.070", "26442778"]}, {"Citation": "Shen B. A new Golden age of natural products drug discovery. Cell. 2015;163(6):1297\u20131300. doi: 10.1016/j.cell.2015.11.031.", "ArticleIdList": ["10.1016/j.cell.2015.11.031", "PMC5070666", "26638061"]}, {"Citation": "Tu Y. Artemisinin-a gift from traditional Chinese medicine to the world (Nobel lecture) Angew Chem. 2016;55(35):10210\u201310226. doi: 10.1002/anie.201601967.", "ArticleIdList": ["10.1002/anie.201601967", "27488942"]}, {"Citation": "Nilsson G, Forsberg-Nilsson K, Xiang Z, Hallbook F, Nilsson K, Metcalfe DD. Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol. 1997;27(9):2295\u20132301. doi: 10.1002/eji.1830270925.", "ArticleIdList": ["10.1002/eji.1830270925", "9341772"]}, {"Citation": "Stempelj M, Ferjan I. Signaling pathway in nerve growth factor induced histamine release from rat mast cells. Inflammation research : official journal of the European Histamine Research Society [et al] 2005;54(8):344\u2013349. doi: 10.1007/s00011-005-1364-7.", "ArticleIdList": ["10.1007/s00011-005-1364-7", "16158335"]}, {"Citation": "Pincelli C, Sevignani C, Manfredini R, Grande A, Fantini F, Bracci-Laudiero L, Aloe L, Ferrari S, Cossarizza A, Giannetti A. Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes. The Journal of investigative dermatology. 1994;103(1):13\u201318. doi: 10.1111/1523-1747.ep12388914.", "ArticleIdList": ["10.1111/1523-1747.ep12388914", "8027574"]}, {"Citation": "Pincelli C. Nerve growth factor and keratinocytes: a role in psoriasis. European journal of dermatology : EJD. 2000;10(2):85\u201390.", "ArticleIdList": ["10694304"]}]}], "History": [{"Year": "2018", "Month": "7", "Day": "16"}, {"Year": "2019", "Month": "10", "Day": "3"}, {"Year": "2019", "Month": "11", "Day": "8", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "11", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["31694615", "PMC6836411", "10.1186/s12906-019-2709-z", "10.1186/s12906-019-2709-z"]}}]}